Posters

A year follow-up clinical experience with intravitreal ocriplasmin injection in vitreomacular traction with or without macular hole

Poster Details

First Author: A.Gorro-Miro SPAIN

Co Author(s):    M. Redon-Soriano   A. Montoliu-Anton   E. Etxabe-Agirre   F. Ramos-Marti                    

Abstract Details



Purpose:

To retrospectively examine six eyes with symptomatic vitreomacular traction (VMT) with or without macular hole (< 400 µm) which were treated with ocriplasmin injection.

Setting:

Hospital General Universitario de Castellón

Methods:

The vitreomacular adhesion and central retinal thickness was measured with spectral domain optical coherence tomography (SD-OCT); baseline best corrected visual acuity, posterior to treatment and at 1 month, 3 months, 6 months and 12 months was evaluated in conjunction with whether there was a neurosensorial detachment or not.

Results:

VMT was resolved in three out of the six treated eyes (50%). Improvement of best corrected visual acuity was achieved in four eyes (66.7%). Closure of macular hole was found in three out of four eyes (100%). Resolution of neurosensorial retinal detachment appeared in two out of three (66.7%).

Conclusions:

Intravitreal ocriplasmin is a safer alternative treatment to pars plana vitrectomy in patients with symptomatic VMT. Proper selection of patients determine functional and anatomical results, but at present, no significant predictors of final outcome have been found.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy